Table 3.
Investment guide posts for PHC (measure 1), across income groups
Year | Low-income countries | Lower-middle-income countries | Upper-middle-income countries | All 67 countries | ||
---|---|---|---|---|---|---|
Costs | ||||||
Total additional cost (recurrent and capital; billion US$) | Sum 2020–30 | 396 | 960 | 858 | 2215 | |
Annual additional cost (billion US$) | ||||||
Recurrent and capital | Average 2020–30 | 36 | 87 | 78 | 200 | |
Recurrent only | Average 2020-30 | 30 | 77 | 72 | 179 | |
Current health expenditure per capita | 2016 | 36 | 84 | 513 | 252 | |
Current per capita PHC expenditure (recurrent only)* | 2016 | 25 | 34 | 304 | 62 | |
Additional PHC per capita cost (US$) | ||||||
Recurrent and capital | Average 2020–30 | 48 | 29 | 32 | 32 | |
Recurrent only | Average 2020–30 | 40 | 25 | 29 | 28 | |
Total recurrent cost per capita for PHC (current per capita PHC expenditure plus additional PHC per capita cost; recurrent only; US$) | 2030 | 65 | 59 | 334 | 90 | |
Health workers | ||||||
Total number of health workers, per 1000 population | Latest year available | 1·4 | 4·6 | 7·9 | 5·6 | |
Health workers needed for PHC services, per 1000 population | 2030 | 5·9 | 6·0 | 8·1 | 6·7 | |
Outpatient visits | ||||||
Total outpatient visits for modelled PHC interventions, per year, per capita | 2030 | 5·7 | 4·0 | 8·7 | 6·0 | |
Incremental outpatient visits for modelled PHC interventions, per year, per capita | 2030 | 4·0 | 2·3 | 3·5 | 3·0 | |
Health impact | ||||||
Total number of deaths averted because of PHC (millions) | Total 2020–30 | 16·2 | 30·6 | 13·5 | 60·1 | |
Gains in life expectancy at birth (years) | 2030 compared with 2015 baseline | 6·7 | 4·0 | 2·3 | 3·7 |
Because of rounding, numbers might not add up. PHC=primary health care. All numbers are in US$ (2014) unless otherwise indicated. All per-capita numbers are population weighted.
Using measure defined as option 5 within Van de Maele and colleagues' study.3